TAK1/MAP4K2 inhibitor 1 50mg

Alternative_Names

NA
CAS

1315330-11-0
Purity

>98%
MWt

552.59
Formula

C29H31F3N6O2
Solubility

10 mM in DMSO
Clinical_Information

No Development Reported
Pathway

MAPK/ERK Pathway;MAPK/ERK Pathway
Target

MAP3K;MAP4K
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Gene target

TAK1/MAP4K2 inhibitor 50mg
Gene symbol

MAP3K7, MAP4K2, NR2C2
Short name

TAK1/MAP4K2 inhibitor 1 50mg
Alternative name

TAK1/mitogen-activated protein kinase kinase kinase kinase 2 suppressor 1 50mg
Alternative to gene target

mitogen-activated protein kinase kinase kinase kinase 2, BL44 and GCK and RAB8IP, MAP4K2 and IDBG-55181 and ENSG00000168067 and 5871, transferase activity, Plasma membranes, Map4k2 and IDBG-135906 and ENSMUSG00000024948 and 26412, MAP4K2 and IDBG-643979 and ENSBTAG00000001037 and 520058